Cite
THERAPEUTIC ANTICOAGULATION IN PREVENTION OF RECURRENT PORTAL VEIN THROMBOSIS AFTER LIVER TRANSPLANTATION: UTILITY OR FUTILITY?
MLA
Bos, Isabel, et al. Therapeutic Anticoagulation in Prevention of Recurrent Portal Vein Thrombosis After Liver Transplantation: Utility or Futility? Aug. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..76dc5502bf4b7e7e6767f8a5a33e2237&authtype=sso&custid=ns315887.
APA
Bos, I., Blondeau, M., Wouters, D., Camus, C., Houssel-Debry, P., Plas, W., Nieuwenhuis, L., Lisman, T., Vincent E. de Meijer, Porte, R. J., & Rayar, M. (2021). Therapeutic Anticoagulation in Prevention of Recurrent Portal Vein Thrombosis After Liver Transplantation: Utility or Futility?
Chicago
Bos, Isabel, Marc Blondeau, Dune Wouters, Christophe Camus, Pauline Houssel-Debry, Willemijn Plas, Lianne Nieuwenhuis, et al. 2021. “Therapeutic Anticoagulation in Prevention of Recurrent Portal Vein Thrombosis After Liver Transplantation: Utility or Futility?,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..76dc5502bf4b7e7e6767f8a5a33e2237&authtype=sso&custid=ns315887.